• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

局部递送抗体与全身性抗生素联合使用可对抗耐药性烧伤创面感染产生协同保护作用。

Locally delivered antibodies combined with systemic antibiotics confer synergistic protection against antibiotic-resistant burn wound infection.

作者信息

Felts A G, Grainger D W, Slunt J B

机构信息

Anthony G. Gristina Institute for Biomedical Research, Herndon, Virginia, USA.

出版信息

J Trauma. 2000 Nov;49(5):873-8. doi: 10.1097/00005373-200011000-00014.

DOI:10.1097/00005373-200011000-00014
PMID:11086779
Abstract

BACKGROUND

Nosocomially derived gram-negative infections, particularly from antibiotic-resistant pathogens, are a cause of morbidity in patients with severe burn wounds.

METHODS

Locally delivered polyclonal antibodies and systemically infused ceftazidime were combined in a lethal murine burn wound model against a virulent Pseudomonas aeruginosa strain that exhibits intermediate resistance to ceftazidime.

RESULTS

Survival was synergistically enhanced in cohorts of burned mice treated both locally (subeschar) with pooled polyclonal human immunoglobulin G (1-mg dose) and intravenously with infused ceftazidime (0.44 mg dose). Enhancement of survival correlated with reduced bacterial quantitation in local and systemic tissue observed in separate burned cohorts. Burned, infected mice treated prophylactically with either individual treatment at the same dose or a combination of both treatments administered systemically showed no survival enhancement as compared with the untreated control group.

CONCLUSION

Treatment of antibiotic-resistant burn wound infections with antibiotics together with locally delivered immunoglobulins may improve antibiotic protective effects against antibiotic-resistant pathogens.

摘要

背景

医院获得性革兰氏阴性菌感染,尤其是来自耐药病原体的感染,是严重烧伤创面患者发病的一个原因。

方法

在致死性小鼠烧伤创面模型中,将局部递送的多克隆抗体与全身输注的头孢他啶联合使用,以对抗对头孢他啶表现出中度耐药的强毒铜绿假单胞菌菌株。

结果

在局部(焦痂下)用混合的多克隆人免疫球蛋白G(1毫克剂量)和静脉内输注头孢他啶(0.44毫克剂量)治疗的烧伤小鼠队列中,生存率得到协同提高。生存率的提高与在单独的烧伤队列中观察到的局部和全身组织中细菌定量减少相关。与未治疗的对照组相比,用相同剂量的单一治疗或全身给予两种治疗的组合进行预防性治疗的烧伤感染小鼠没有显示出生存率提高。

结论

用抗生素和局部递送的免疫球蛋白治疗耐药性烧伤创面感染可能会提高抗生素对耐药病原体的保护作用。

相似文献

1
Locally delivered antibodies combined with systemic antibiotics confer synergistic protection against antibiotic-resistant burn wound infection.局部递送抗体与全身性抗生素联合使用可对抗耐药性烧伤创面感染产生协同保护作用。
J Trauma. 2000 Nov;49(5):873-8. doi: 10.1097/00005373-200011000-00014.
2
Locally delivered polyclonal antibodies potentiate intravenous antibiotic efficacy against gram-negative infections.局部递送的多克隆抗体可增强静脉注射抗生素对革兰氏阴性菌感染的疗效。
Pharm Res. 2002 Dec;19(12):1801-7. doi: 10.1023/a:1021481122011.
3
Efficacy of locally delivered polyclonal immunoglobulin against Pseudomonas aeruginosa infection in a murine burn wound model.局部递送多克隆免疫球蛋白对小鼠烧伤创面模型中铜绿假单胞菌感染的疗效。
Burns. 1999 Aug;25(5):415-23. doi: 10.1016/s0305-4179(99)00017-0.
4
Efficacy of antibodies against the N-terminal of Pseudomonas aeruginosa flagellin for treating infections in a murine burn wound model.抗铜绿假单胞菌鞭毛蛋白N端抗体在小鼠烧伤创面模型中治疗感染的疗效。
Plast Reconstr Surg. 2006 Jun;117(7):2284-91. doi: 10.1097/01.prs.0000218768.34429.e0.
5
Therapeutic efficacy of "nubiotics" against burn wound infection by Pseudomonas aeruginosa.“新型抗生素”对铜绿假单胞菌所致烧伤创面感染的治疗效果。
Antimicrob Agents Chemother. 2004 Aug;48(8):2918-23. doi: 10.1128/AAC.48.8.2918-2923.2004.
6
Application of 63 AM supernatant to infected wounds prevents sepsis in murine models of thermal injury and dorsal excision.63 AM 上清液在感染性伤口中的应用可预防热损伤和背部切除的小鼠模型中的脓毒症。
J Med Microbiol. 2019 Oct;68(10):1560-1572. doi: 10.1099/jmm.0.001066. Epub 2019 Aug 22.
7
Phage therapy of Pseudomonas aeruginosa infection in a mouse burn wound model.铜绿假单胞菌感染小鼠烧伤创面模型的噬菌体治疗
Antimicrob Agents Chemother. 2007 Jun;51(6):1934-8. doi: 10.1128/AAC.01028-06. Epub 2007 Mar 26.
8
Improvement in survival with peptidyl membrane interactive molecule D4B treatment after burn wound infection.
Arch Surg. 1998 Jul;133(7):715-20. doi: 10.1001/archsurg.133.7.715.
9
[Prevention of gram-negative and gram-positive infections with 3 intravenous immunoglobulin preparations and therapy of experimental polymicrobial burn infection with intravenous Pseudomonas immunoglobulin G and ciprofloxacin in an animal model].[用3种静脉注射免疫球蛋白制剂预防革兰氏阴性和革兰氏阳性感染以及在动物模型中用静脉注射铜绿假单胞菌免疫球蛋白G和环丙沙星治疗实验性多微生物烧伤感染]
Infection. 1987;15 Suppl 2:S51-9. doi: 10.1007/BF01644193.
10
Passive immunization against Pseudomonas aeruginosa recombinant PilA in a murine burn wound model.在小鼠烧伤创面模型中针对铜绿假单胞菌重组菌毛蛋白A进行被动免疫。
Microb Pathog. 2016 Dec;101:83-88. doi: 10.1016/j.micpath.2016.10.027. Epub 2016 Nov 9.

引用本文的文献

1
Polyvalent human immunoglobulin for infectious diseases: Potential to circumvent antimicrobial resistance.多价人免疫球蛋白治疗传染病:克服抗菌药物耐药性的潜力。
Front Immunol. 2023 Jan 9;13:987231. doi: 10.3389/fimmu.2022.987231. eCollection 2022.
2
Subeschar culture using a punch instrument in unstageable wounds.在无法分期的伤口中使用打孔器械进行焦痂下培养。
Arch Plast Surg. 2020 May;47(3):228-234. doi: 10.5999/aps.2019.01641. Epub 2020 May 15.
3
Negative pressure wound therapy decreases mortality in a murine model of burn-wound sepsis involving Pseudomonas aeruginosa infection.
负压伤口治疗可降低铜绿假单胞菌感染所致烧伤创面脓毒症小鼠模型的死亡率。
PLoS One. 2014 Feb 28;9(2):e90494. doi: 10.1371/journal.pone.0090494. eCollection 2014.
4
Wound bed preparation from a clinical perspective.从临床角度看伤口床准备
Indian J Plast Surg. 2012 May;45(2):193-202. doi: 10.4103/0970-0358.101277.
5
Antibodies in infectious diseases: polyclonals, monoclonals and niche biotechnology.传染病中的抗体:多克隆抗体、单克隆抗体和利基生物技术。
N Biotechnol. 2011 Sep;28(5):489-501. doi: 10.1016/j.nbt.2011.03.018. Epub 2011 Apr 5.
6
Locally delivered polyclonal antibodies potentiate intravenous antibiotic efficacy against gram-negative infections.局部递送的多克隆抗体可增强静脉注射抗生素对革兰氏阴性菌感染的疗效。
Pharm Res. 2002 Dec;19(12):1801-7. doi: 10.1023/a:1021481122011.